# A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors

> **NCT05393063** · PHASE1 · UNKNOWN · sponsor: **Akeso** · enrollment: 36 (estimated)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** AK127

## Key facts

- **NCT ID:** NCT05393063
- **Lead sponsor:** Akeso
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06
- **Primary completion:** 2023-06
- **Final completion:** 2024-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2022-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05393063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05393063, "A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05393063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*